Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-057505

Chairman and CEO bought 3,582 shares at an average $1.68 ($6,017)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-09-21 Purchase +2,000 $1.64 $3,280 10,877,065 D: show line 1 in the form
Niihara Yutaka Chairman and CEO 2021-09-22 Purchase +1,582 $1.73 $2,737 10,878,647 D: show line 2 in the form
Open-market purchases · 3,582 sh · avg $1.68 · $6,017
Loading xslF345X03/doc4.xml…